Stem Cell Therapy International Corp. to Present Histostem, Co., Ltd. Merger Opportunity at Investment Banker’s Conference May 1 - 3, 2008

TAMPA, FL and SEOUL, SOUTH KOREA--(Marketwire - April 30, 2008) - Calvin Cao, CEO of Stem Cell Therapy International, Inc. (OTCBB: SCII) announced today that he and the newly appointed president, David Stark, will be attending the FSX - Financial Services Exchange (www.fsx1.com/fsx), investment banker’s conference in Marina Del Rey, California, May 1 - 3, 2008. The three day event will give Mr. Cao and Mr. Stark an opportunity to meet one-on-one with as many as 40 different investment banking firms and broker-dealers so these leading brokerage and financial services companies can be fully informed with regards to the pending merger between Stem Cell Therapy International and Histostem Co., Ltd. of Korea. David Stark will make the formal speech and slide-show presentation regarding the merger opportunity to all attending conference members on Saturday morning.

MORE ON THIS TOPIC